Paion 過去の業績
過去 基準チェック /06
Paion's earnings have been declining at an average annual rate of -1074.5%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 48.5% per year.
主要情報
-1,074.5%
収益成長率
-1,070.2%
EPS成長率
| Biotechs 業界の成長 | -14.6% |
| 収益成長率 | -48.5% |
| 株主資本利益率 | n/a |
| ネット・マージン | -134.1% |
| 前回の決算情報 | 30 Jun 2023 |
最近の業績更新
Recent updates
収支内訳
Paion の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 23 | 15 | -20 | 20 | 5 |
| 31 Mar 23 | 24 | -10 | 21 | 6 |
| 31 Dec 22 | 33 | -1 | 21 | 6 |
| 30 Sep 22 | 27 | -3 | 22 | 6 |
| 30 Jun 22 | 29 | -2 | 21 | 5 |
| 31 Mar 22 | 18 | -12 | 21 | 5 |
| 31 Dec 21 | 7 | -22 | 20 | 5 |
| 30 Sep 21 | 6 | -20 | 15 | 6 |
| 30 Jun 21 | 20 | -2 | 13 | 7 |
| 31 Mar 21 | 18 | -1 | 10 | 8 |
| 31 Dec 20 | 20 | 2 | 8 | 10 |
| 30 Sep 20 | 20 | 2 | 7 | 12 |
| 30 Jun 20 | 4 | -14 | 6 | 13 |
| 31 Mar 20 | 12 | -5 | 6 | 14 |
| 31 Dec 19 | 8 | -7 | 5 | 13 |
| 30 Sep 19 | 10 | -5 | 4 | 13 |
| 30 Jun 19 | 10 | -3 | 4 | 12 |
| 31 Mar 19 | 3 | -10 | 4 | 12 |
| 31 Dec 18 | 3 | -10 | 3 | 12 |
| 30 Sep 18 | 1 | -12 | 4 | 13 |
| 30 Jun 18 | 2 | -13 | 4 | 14 |
| 31 Mar 18 | 4 | -13 | 4 | 17 |
| 31 Dec 17 | 6 | -12 | 4 | 18 |
| 30 Sep 17 | 7 | -13 | 4 | 21 |
| 30 Jun 17 | 8 | -13 | 4 | 21 |
| 31 Mar 17 | 6 | -16 | 5 | 21 |
| 31 Dec 16 | 4 | -20 | 5 | 23 |
| 30 Sep 16 | 2 | -24 | 5 | 25 |
| 30 Jun 16 | 0 | -30 | 6 | 30 |
| 31 Mar 16 | 0 | -30 | 6 | 30 |
| 31 Dec 15 | 0 | -28 | 6 | 29 |
| 30 Sep 15 | 2 | -23 | 6 | 26 |
| 30 Jun 15 | 2 | -17 | 5 | 19 |
| 31 Mar 15 | 3 | -12 | 4 | 16 |
| 31 Dec 14 | 3 | -9 | 4 | 12 |
| 30 Sep 14 | 5 | -5 | 4 | 8 |
| 30 Jun 14 | 5 | -4 | 3 | 7 |
| 31 Mar 14 | 3 | -4 | 3 | 5 |
| 31 Dec 13 | 4 | -2 | 3 | 5 |
質の高い収益: PA8K is currently unprofitable.
利益率の向上: PA8K is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: Insufficient data to determine if PA8K's year-on-year earnings growth rate was positive over the past 5 years.
成長の加速: Unable to compare PA8K's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: PA8K is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).
株主資本利益率
高いROE: PA8K's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.